Jan 29, 2021 by Olivia ZitkusHere's How the Genetic Testing Industry Can Get Even BiggerGenetic testing companies have to appeal to several stakeholders in the healthcare system in order to make it to the next level.
Dec 30, 2020 by Olivia ZitkusHere's What A Doctor Thinks Are The Biggest Vaccination ChallengesVaccination logistics can make vaccine development look easy.
Dec 30, 2020 by Olivia ZitkusBeyond Pfizer and Moderna: What Investors Need to Know About the Next COVID Vaccines in The PipelineNow that two coronavirus vaccines have been authorized for use, it's a serious question whether people will be willing to participate in other clinical trials months down the road.
Dec 29, 2020 by Olivia ZitkusCOVID Vaccine Stocks: The Hares Have Won, But Watch the TortoisesThey were first to cross the finish line, but that doesn't mean their coronavirus vaccines will be the best.
Dec 29, 2020 by Olivia ZitkusAsk A Doctor: Here's How The U.S. Can Reach Herd ImmunityIt'll be all about vaccine supply over the next several months.
Dec 28, 2020 by Olivia ZitkusWhat Should Investors Know About FDA Decisions On COVID Vaccines?Investors can learn new and actionable information about coronavirus vaccines through public FDA advisory committee meetings.
Dec 28, 2020 by Olivia ZitkusAsk A Doctor: What Does The Post-Pandemic World Look Like?The end of the coronavirus pandemic is coming into view. But some new practices, processes, and innovations might not be going anywhere, even after herd immunity is reached.
Dec 28, 2020 by Olivia ZitkusA Vaccination Expert On What Investors Need To Know About COVID Vaccines NowEven though two vaccines have been authorized, investors in the coronavirus vaccine race shouldn't rest just yet.
Dec 27, 2020 by Olivia ZitkusA Public Health Expert on the Coronavirus Vaccine: Who Should Be Immunized Next?Over one million Americans have already received their first coronavirus vaccine dose. There are 327 million to go.
Dec 27, 2020 by Olivia ZitkusYou're Going to Want to Hear This Doctor's Advice on Buying COVID Vaccine StocksTwo coronavirus vaccines have already received Emergency Use Authorization in the U.S., but the true winner might not be who you think.
Dec 26, 2020 by Olivia ZitkusVaccination Expert: What Investors Should Watch In 2021Coronavirus vaccines are here (in record time). But there's still a lot we have to learn about them.
Dec 26, 2020 by Olivia ZitkusAsk A Vaccine Specialist: What Does The Future of the mRNA Platform Hold?Its use in a coronavirus vaccine is an exciting step forward, but mRNA technology is unlikely to solve all of our problems.
Dec 25, 2020 by Olivia ZitkusWhat Should Investors Know About 2-Dose COVID Vaccines?A vaccination expert unpacks the challenges presented by a two-dose schedule.
Dec 25, 2020 by Olivia ZitkusWhat We Still Don't Know About COVID Vaccines (And How We'll Get Answers)It'll take more time and new studies in order to know how well the new vaccines are slowing the spread.
